ReviewFrontiers in genetics2022

Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors.

Elena Alexandrova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.